C. diff. Spores and More

Join us with our guests: Caitlin Stowe is a master’s prepared infection preventionist currently employed with PDI as the Clinical Affairs Research Manager and

Megha Patel is a Senior Product Manager with PDI, focused on new product development. Both professionals will be discussing innovation in

C. difficile prevention.

Join us with our guests: Caitlin Stowe is a master’s prepared infection preventionist currently employed with PDI as the Clinical Affairs Research Manager and

Megha Patel is a Senior Product Manager with PDI, focused on new product development. Both professionals will be discussing innovation in

C. difficile prevention.

Join us with Guest: Henry R Herrera Jr., MD, a Gastroenterology specialist. Dr. Herrera will be discussing the complications of a C. diff. infection and Inflammatory Bowel Disease (IBD). His professional experience and expertise is in Gastroenterology and places Dr. Herrera at the forefront of diagnosing, treating, and caring for patients experiencing the symptoms of the many diagnosis associated with the Gastrointestinal system.

Join us with our guest: Maureen Spencer, RN, M.Ed., CIC joining us to discuss an array of important topics:

1. Overuse and inappropriate prescribing of antibiotics worldwide is leading to the global healthcare issue of antibiotic resistance. 2. Empiric antibiotics are used consistently in healthcare when infection is suspected

3. Empiric antibiotics are prescribed to cover gram positive, gram negative and yeast infections until the final lab result is available 4. Overuse of antibiotics adversely effect the normal flora and microbiome in the body depleting colonies of bacteria that are necessary for digestion and protection. 5. When the microbiome is depleted other resistant species overgrow on the skin and in the systems of the body, especially the gut. 6. Multiple Drug Resistant organisms MDRO include MRSA, VRE, ESBL and CRE that will grow in patients who have been on antibiotics AND MUCH MORE.

Join us with guest Sahil Khanna, MD, M.B.B.S

Dr. Khanna, MD, MBBS, is an Assistant Professor of Medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic, Rochester, MN.

Dr. Khanna will be discussing Antibiotics treating

C. difficile infections, clinical trials, and Investigations Treatments.

Join us with guests Ron Romano, RN and Jenn Robke, RN as they discuss the main question in today's episode is not what products are being utilized to address germs and bacteria. Listen in to learn more

Join our guests Beatrix M. Babcock, MS HSA, LPN and

Michael Kupneski is the R and ;D Section Head for Procter and Gamble Professional. Both guests will be discussing the importance of disinfection and sanitizing soft surfaces in health care environments.

Guest Kevin Hersh, an International Health Coach, joins us to discuss the tools that are able to create positive effects while coping with the stressors of returning back to school, and maintaining the balance in life.

Professor Simon Cutting joins us and shares his thoughts and scientific research focused on

C.difficile prevention, treatments, and probiotics.

The C.diff. infection concept of 20 years ago is not what it is today. Professor Cutting reviews the landscape of C.difficile from the farms, animals, to humans and the differences from country to country.

Join us with guest Bernat Olle, MS, PhD as we discuss

Defined Bacterial Consortia for Prevention of a C. difficile infection (CDI) Recurrence.